Willem Koetse
Willem Koetse publishes mostly in Rheumatology, Immunology and Genetics, on topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Chronic Lymphocytic Leukemia Research.
- World rank
- #2,498,251 of 7,710,434 ranked researchers
- Rank in Belgium
- #22,730 of 67,186
- Works
- 20
- Citations
- 412
- Citations per work
- 20.6
What does Willem Koetse research?
Willem Koetse's work is mostly in Medicine (48%), Immunology and Microbiology (18%), Social Sciences (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1048.3%
- Medicine1048.3%
- Everything else523.4%
- Life Sciences418.3%
- Social Sciences210.0%
- Social Sciences16.7%
- Psychology13.3%
- 1Rheumatology33% of their works
- 2Immunology18% of their works
- 3Genetics8% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Sociology and Political Science7% of their works
- 6Clinical Psychology3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Chronic Lymphocytic Leukemia Research
- Biosimilars and Bioanalytical Methods
- Monoclonal and Polyclonal Antibodies Research
- Psoriasis: Treatment and Pathogenesis
- Systemic Lupus Erythematosus Research
- Criminal Justice and Corrections Analysis
Which keywords describe Willem Koetse's research?
The keywords of their largest research topics: Autoantibodies, Inflammation, Rheumatoid Arthritis, Monoclonal Antibodies, Ankylosing Spondylitis, Spondyloarthritis, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- TH17 Cells
- Mass Incarceration
- Criminal Justice
- Therapeutic Antibodies
- Fc Receptors
- Genomic Aberrations
- Spondyloarthritis
- Monoclonal Antibodies
- Inflammation
- Autoantibodies
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Chronic Lymphocytic Leukemia
- Biosimilars
- Immunogenicity
- Antiphospholipid Syndrome
- IL-17
- Systemic Lupus Erythematosus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Autoantibodies132 topics
- Inflammation101 topic
- Rheumatoid Arthritis101 topic
- Monoclonal Antibodies82 topics
- Ankylosing Spondylitis71 topic
- Spondyloarthritis71 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Biosimilars41 topic
- Fc Receptors41 topic
- Immunogenicity41 topic
- Therapeutic Antibodies41 topic
- Antiphospholipid Syndrome31 topic
- Criminal Justice31 topic
- IL-1731 topic
- Mass Incarceration31 topic
- Systemic Lupus Erythematosus31 topic
- TH17 Cells31 topic
Where does Willem Koetse work?
Willem Koetse's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Willem Koetse have?
OpenAlex counts 20 works and 412 citations for Willem Koetse, an h-index of 9, ranking #2,498,251 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Willem Koetse. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.